Varian Acquires IonSpec
By Biotechdaily staff writers
Posted on 10 Mar 2006
Varian, Inc. (Palo Alto, CA, USA) has acquired IonSpec Corp. (Lake Forest, CA, USA) for approximately U.S.$16 million. Posted on 10 Mar 2006
Varian said the acquisitions of IonSpec's Fourier transform mass spectrometry (FTMS) technology represents a significant step toward expanding its information-rich detection (IRD) portfolio.
Varian expects the acquisition to increase its development of growing life science applications, specifically the study of proteins, nucleic acids, and drug metabolites. The initial cash purchase price includes paying down assumed debt and an opportunity for an additional payment if FTMS products reach specified financial targets over a three-year period.
FTMS instruments are used in laboratories worldwide to determine the function and structural characterization of proteins and other biomolecules in various biologic systems.
Related Links:
Varian
IonSpec
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
